Schedule 13D ownership disclosure

BLAKE INSOMNIA THERAPEUTICS IN COM

Security class unavailable · CUSIP: 093152106

Event date: 2015-08-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
18,000,000
Percent of class
57.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001663577-17-000210
Form type
SC 13D
Filer
Blake Insomnia Therapeutics, Inc.
CIK
CIK 1556416
Filed
Jul 13, 2017
Reporting period
Aug 31, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub